Skip to content

Advertisement

Featured article: Current understanding of the molecular mechanisms in Parkinson's disease

New Content ItemThis review provides basic conceptual information on the molecular mechanisms underlying Parkinson’s Disease, which may assist in the design of more effective drugs or other treatment strategies.

Read the article

Articles

Editor-in-Chief

Shengdi Chen, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China 

Journal news

The publication costs for Translational Neurodegeneration are fully covered by Ruijin Hospital, Shanghai Jiaotong University School of Medicine until 31st July 2018. For new submissions from 1st August 2018, authors will need to pay an article publishing charge (APC) of £1370.00/$2145.00/€1745.00 for each article submitted and accepted for publication in the journal.

Aims and Scope

Translational Neurodegeneration is an open access, peer-reviewed journal that covers research, therapeutics and education for all aspects of neurodegenerative diseases. By offering a high-visibility forum for new insights and discussions, Translational Neurodegeneration creates a novel interface between the fields of basic, translational, and clinical research. It includes Parkinson's disease and movement disorders, Alzheimer's disease and other dementias, motor neuron disease and other neurodegenerative diseases.

Read more

Advertisement

Affiliated with

  • Ruijin hospital_2

2017 Journal Metrics

Advertisement